Company intelligence / Profile preview

Fosun Aitrox

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

Fosun Aitrox has released over 70 AI-based diagnostic products used clinically in China across radiology, pathology, and ultrasound imaging. The company is recognized for integration across multiple medical specialties and its solutions are widely deployed in hospitals and medical centers, winning awards in international competitions and supporting smart healthcare at scale.[1][2][5]

Therapeutic areas: CardiovascularEndocrinologyPulmonologyNeurologyWomen's HealthOtherOncology
Modalities: DeviceDigital health platformSoftwareArtificial intelligence
Industry: Medical Imaging

Partnerships

Fosun PharmaSinopharm-CICC (Shanghai) Private Equity Investment Management Co.

Beyond the preview

Go deeper on Fosun Aitrox.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fosun Aitrox.

Explore the full profile